Search Results

Total: 2 , 1/1

Show Home Prev Next End page: GO

MeSH:(Incretins/therapeutic use*)

1.Benefit-risk assessment of incretin and other anti-diabetic agents in type 2 diabetes using a stochastic multicriteria acceptability analysis model.

Sanbao CHAI ; Shuqing YU ; Fengqi LIU ; Zuoxiang LIU ; Qingqing YANG ; Feng SUN

Chinese Medical Journal 2023;136(1):102-104

2.Glucagon-like peptide-1 based therapy for type 2 diabetes.

Chinese Journal of Pediatrics 2006;44(9):669-671

Sort by

Result Analysis

Display Mode

Brief Abstract

Selected Records All Records

Output Records

All Records(≤500)
Selected Records
All Records on Page
Records To (≤500)

File Type

Normal
NoteExpress
Refworks
EndNote
XML

Print

Save

E-mail

Total: 2 , 1/1 Show Home Prev Next End page: GO